Bharat Parenterals Limited
BPLPHARMA.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.83B
Close$
Share Statistics
| Market cap | $12.83 Billion |
|---|---|
| Enterprise Value | $12.83 Billion |
| Dividend Yield | $1.00 (0.11%) |
| Earnings per Share | $-39.62 |
| Beta | 0.73 |
| Outstanding Shares | 6,891,963 |
Return
| Return on Equity | -4.95% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -60.58 |
|---|---|
| PEG | 69.04 |
| Price to Sales | 4.04 |
| Price to Book Ratio | 4.19 |
| Enterprise Value to Revenue | 3.97 |
| Enterprise Value to EBIT | -84.08 |
| Enterprise Value to Net Income | -84 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bharat Parenterals Limited
404 employees
CEO: Bharatkumar Rameshchandra Desai Bharat Parenterals Limited specializes in the development and production of pharmaceutical formulations, offering a broad spectrum of products. Their diverse portfolio encompasses general-purpose medicines, B-Lactam compounds, cephalospo...